---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-24-000015"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2024-02-23T23:59:59+00:00"
generated_at: "2026-06-05T16:26:59.198961+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ANI Pharmaceuticals sells former Oakville, ON manufacturing facility for C$19.2M (US$14.2M)

## Summary
- Purchase price C$19.2M (~US$14.2M); buyer paid 5% deposit (~US$710k) with second 5% after due diligence.
- Buyer has 5 business day due diligence period; closing expected by end of March 2024.
- Sale includes land, building (~101,111 sq ft), chattels and fixtures; sold 'as is' with customary conditions.
- ANI retains deposits if buyer defaults; deposits returned if ANI defaults or due diligence fails.

## SEC filing metadata
- accession: 0001023024-24-000015
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2024-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000015/0001023024-24-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000015/ani-20240216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-24-000015
- JSON: https://secwatch.observer/filing/0001023024-24-000015.json
- Plain text: https://secwatch.observer/filing/0001023024-24-000015.txt

## Key facts
- Material Agreements
  ANI PHARMACEUTICALS INC entered into Agreement with 1540700 Ontario Limited valued at $19,200,000 Canadian dollars (effective 2024-02-16).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: 1540700 Ontario Limited
  - Value: $19,200,000 Canadian dollars
  - Effective: 2024-02-16
  source text: On February 16, 2024, ANI Pharmaceuticals Canada Inc., a wholly owned subsidiary of ANI Pharmaceuticals, Inc. (“ANI”) entered into an agreement (the “Agreement”) with 1540700 Ontario Limited (“Buyer”) for the purchase and sale of ANI’s Oakville, Ontario former manufacturing facility (the “Property”) at a total purchase price of $19,200,000 Canadian dollars
  evidence_url: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000015/0001023024-24-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.